Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Sanofi Foundation opens new chapter centered on future generations
- 6/25/2026 1:04:01 PM
- The Sanofi Foundation is opening a new chapter with a strengthened commitment to children and young people, particularly those living with serious diseases.
- Socioeconomic Challenges Color Patients’ Lung Cancer Screening Experience
- 6/24/2026 11:00:53 AM
- New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is generally well tolerated both physically and emotionally, but experiences vary across socioeconomic groups.
- Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
- 6/23/2026 11:23:27 AM
- • Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopenia (ITP) • Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other symptoms • ITP is a rare disease of complex immune dysregulation leading to lower platelet counts, …
- Are certain demographic, birth, and parental characteristics linked to an increased risk of early-onset colorectal cancer?
- 6/23/2026 10:57:24 AM
- A recent study found that factors such as a person’s birthweight, sex, ethnicity, and father’s age may affect the risk of being diagnosed with colorectal cancer at a young age.
- Sanofi appoints Paulo Fontoura as Global Head of R&D
- 6/22/2026 7:21:08 PM
- Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1, 2026.
- AdvaMed Earns WTOP News Regional Top Workplaces 2026 Award, Culture Excellence Awards
- 6/22/2026 8:27:24 AM
- AdvaMed, the largest trade association representing medtech innovators, announced it is a WTOP News Top Workplaces 2026 award winner in the Washington, D.C., region and received five Culture Excellence awards.
- Senate panel passes NO FAKES Act; AMA urges Congressional approval
- 6/22/2026 8:16:18 AM
- Statement attributable to: John Whyte, MD, MPH CEO, American Medical Association “The NO FAKES Act is the real deal—an important step toward ensuring that innovation serves people, not those seeking to deceive them.
- Vali Health Raises $6M to Build Responsible AI Infrastructure for Home Care Agencies
- 6/17/2026 9:35:05 AM
- Vali Health, a startup building responsible AI infrastructure for the home care industry, today emerged from stealth with $6 million in funding from Bonfire Ventures, Supernode, Comma Capital, along with Jacquelyn Kung, an industry veteran who built two of the largest software platforms for home care.
- Heartseed Announces First Patient Dosed in a Phase I/II EMERALD Study with HS-005 – a Cell Therapy Administered via Catheter, Designed to Restore Heart Function in People with Severe Heart Failure
- 6/15/2026 12:16:05 PM
- Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation (Nikon), manufactures iPSC-derived purified cardiomyocyte spheroids of HS-005, under contract to Heartseed Inc.(Heartseed).
- CONV2X Announces Smart Technology Transformation in Healthcare & Life Sciences Summit in New York City
- 6/15/2026 10:56:45 AM
- CONV2X Smart Technology Transformation in Healthcare & Life Sciences, announced its annual two-day executive summit taking place October 29–30, 2026 at the Historic GE Building, ILR Conference Center, 570 Lexington Avenue, New York, NY.
- Elsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak
- 6/15/2026 10:54:14 AM
- Following the World Health Organization’s declaration of an Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern (PHEIC), Elsevier, a global leader in scientific information and analytics, has launched its Ebola Information Center to provide healthcare professionals, researchers, …
- Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy
- 6/15/2026 10:48:37 AM
- Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in proteinuria vs placebo at 34 weeks If approved, Ultomiris would be the first C5 complement inhibitor available for this rare kidney disease Alexion, AstraZeneca Rare Disease’s supplemental Biologics License Application (sBLA) for …
- Caring for non-communicable diseases during pregnancy, expert convening
- 6/15/2026 10:36:28 AM
- The World Health Organization (WHO) is developing new recommendations to improve care for pregnant and postpartum women living with noncommunicable diseases (NCDs).
- “Beyond Feet on Fire” is Free to Download for Only Five Days (Until 6/19/26)
- 6/15/2026 6:00:00 AM
- Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for only five days.
- Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
- 6/12/2026 10:38:47 AM
- • Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. • Cataracts are one of the leading causes of vision impairment.1 Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.2 • Over half a million eyes worldwide …
- Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
- 6/10/2026 6:17:01 PM
- Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped.
- Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - May 2026
- 6/10/2026 9:20:39 AM
- At the mid-way point of Immunization Agenda 2030 (IA2030), countries gathering at the Seventy-ninth World Health Assembly (WHA79) marked an important moment in reaffirming their commitment to reaching everyone, everywhere with life-saving vaccines.
- AMA adopts new policies to improve affordable access to obesity treatments
- 6/9/2026 9:02:36 AM
- Physicians and medical students convened for the Annual Meeting of the American Medical Association’s (AMA) House of Delegates today and adopted new policies aimed at improving patient access to evidence-based obesity treatments while advancing broader efforts to address prescription drug affordability and insurance coverage barriers.
- 3D-printed devices could streamline the production of drug-delivery microparticles
- 6/9/2026 8:39:59 AM
- MIT researchers have demonstrated a low-cost design of specialized electronic nozzles, called triaxial electrospray emitters, that could be used to manufacture time-release drug-delivery particles or self-healing materials efficiently and at scale.
- Wiley Launches Advanced Brain to Push Disciplinary Boundaries Across Neuroscience & Related Fields
- 6/9/2026 8:08:00 AM
- Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Brain, an open access, interdisciplinary journal dedicated to publishing cutting-edge research across neuroscience, neurology, psychiatry and psychology.